A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy-Reference-Cited by-同舟云学术

A population K-PD model analysis of long-term testosterone inhibition in prostate cancer patients undergoing intermittent androgen deprivation therapy

Published:2021-02-04 Issue: Volume: Page:
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

DeJongh Joost^ORCID,Ahsman Maurice^ORCID,Snelder Nelleke^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s10928-020-09736-7.pdf

Reference40 articles.

1. Morote J, Planas J, Salvador C et al (2009) Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy. BJU Int 103:332–335. https://doi.org/10.1111/j.1464-410X.2008.08062.x

2. Oefelein MG, Resnick MI (2003) Effective testosterone suppression for patients with prostate cancer: is there a best castration? Urology 62:207–213. https://doi.org/10.1016/S0090-4295(03)00331-5

3. Spitz A, Young JM, Larsen L et al (2012) Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer. Prostate Cancer Prostatic Dis 15:93–99. https://doi.org/10.1038/pcan.2011.50

4. Cornford P, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol 71:630–642. https://doi.org/10.1016/j.eururo.2016.08.002

5. Pickles T, Hamm J, Morris WJ et al (2012) Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter? BJU Int 110:E500–E507. https://doi.org/10.1111/j.1464-410X.2012.11190.x

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Obesity and Calorie Restriction on Cancer Development;International Journal of Molecular Sciences;2023-05-31